Average Co-Inventor Count = 9.10
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Usher III Initiative, Inc. (9 from 9 patents)
2. Galapagos Nv (8 from 116 patents)
3. Enyo Pharma (6 from 7 patents)
4. Abbvie Overseas Sarl (5 from 5 patents)
5. Abbvie S.a.r.l. (3 from 15 patents)
6. Chdi Foundation, Inc. (2 from 53 patents)
25 patents:
1. 12281116 - HTT modulators for treating Huntington's disease
2. 11840527 - Non-fused thiophene derivatives and their uses
3. 11806346 - HTT modulators for treating Huntington's disease
4. 11807618 - Thiophene derivatives as antiviral agents
5. 11767316 - Non-fused thiophene derivatives and their uses
6. 11603368 - Fused thiophene derivatives and their uses
7. 11492347 - Fused thiophene derivatives and their uses
8. 11279683 - Thiophene derivatives as antiviral agents
9. 10988454 - Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
10. 10981890 - Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
11. 10844041 - Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
12. 10844042 - Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
13. 10829473 - Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
14. 10428017 - Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
15. 10307422 - Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndrome